Cargando…
Whole-genome sequencing identifies new genetic alterations in meningiomas
The major known genetic contributor to meningioma formation was NF2, which is disrupted by mutation or loss in about 50% of tumors. Besides NF2, several recurrent driver mutations were recently uncovered through next-generation sequencing. Here, we performed whole-genome sequencing across 7 tumor-no...
Autores principales: | Tang, Mei, Wei, Heng, Han, Lu, Deng, Jiaojiao, Wang, Yuelong, Yang, Meijia, Tang, Yani, Guo, Gang, Zhou, Liangxue, Tong, Aiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370023/ https://www.ncbi.nlm.nih.gov/pubmed/28177878 http://dx.doi.org/10.18632/oncotarget.15043 |
Ejemplares similares
-
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
por: Yang, Meijia, et al.
Publicado: (2017) -
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
por: He, Juan, et al.
Publicado: (2021) -
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
por: Tang, Xin, et al.
Publicado: (2019) -
Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
por: Tang, Xin, et al.
Publicado: (2020) -
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
por: Zhang, Jinghui, et al.
Publicado: (2013)